Cyclerion Therapeutics Inc
(CYCN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,647 | -40,872 | -29,581 | -13,399 | -77,802 |
| Depreciation Amortization | 472 | 424 | 376 | 258 | 2,297 |
| Accounts receivable | 27 | -31 | 127 | 127 | 1,346 |
| Accounts payable and accrued liabilities | 393 | -261 | -49 | -340 | -1,096 |
| Other Working Capital | 1,408 | -1,706 | -2,614 | -3,614 | -7,592 |
| Other Operating Activity | 12,830 | 14,559 | 11,777 | 2,513 | 10,357 |
| Operating Cash Flow | $-36,517 | $-27,887 | $-19,964 | $-14,455 | $-72,490 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1,457 | 1,457 | 1,464 | 1,462 | 18 |
| Investing Cash Flow | $1,457 | $1,457 | $1,464 | $1,462 | $18 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 3,509 |
| Common Stock Issued | 282 | 197 | 160 | 27 | 331 |
| Other Financing Activity | 30,503 | 30,503 | 30,497 | 0 | 24,250 |
| Financing Cash Flow | $30,785 | $30,700 | $30,657 | $27 | $28,090 |
| Exchange Rate Effect | 4 | 1 | 1 | N/A | -7 |
| Beginning Cash Position | 58,232 | 58,232 | 58,232 | 58,232 | 102,621 |
| End Cash Position | 53,961 | 62,503 | 70,390 | 45,266 | 58,232 |
| Net Cash Flow | $-4,271 | $4,271 | $12,158 | $-12,966 | $-44,389 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,517 | -27,887 | -19,964 | -14,455 | -72,490 |
| Capital Expenditure | -7 | -7 | N/A | N/A | -1,524 |
| Free Cash Flow | -36,524 | -27,894 | -19,964 | -14,455 | -74,014 |